Click Here for 5% Off Your First Aladdin Purchase!

MLN0905 - 97%, high purity , CAS No.1228960-69-7, Inhibitor of polo like kinase 1

  • Moligand™
  • ≥97%
Item Number
M126487
Grouped product items
SKUSizeAvailabilityPrice Qty
M126487-2mg
2mg
In stock
$85.90
M126487-5mg
5mg
In stock
$177.90
M126487-10mg
10mg
In stock
$300.90
M126487-25mg
25mg
In stock
$677.90
M126487-50mg
50mg
In stock
$959.90
M126487-100mg
100mg
In stock
$1,728.90
M126487-250mg
250mg
In stock
$3,888.90
View related series
polo like kinase 1 Inhibitor

Basic Description

SynonymsMLN0905|1228960-69-7|PLK1 Inhibitor|2-[[5-[3-(dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione|2-(5-(3-(DIMETHYLAMINO)PROPYL)-2-METHYLPYRIDIN-3-YLAMINO)-9-(TRIFLUOROMETHYL)-5H-BENZO[B]
Specifications & Purity97%
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionInhibitor of polo like kinase 1

Associated Targets

PLK1 Tchem Serine/threonine-protein kinase PLK1 2 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

Pubchem Sid488201272
Pubchem Sid Urlhttps://pubchem.ncbi.nlm.nih.gov/substance/488201272
IUPAC Name 2-[[5-[3-(dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione
INCHI InChI=1S/C24H25F3N6S/c1-14-19(9-15(12-28-14)5-4-8-33(2)3)31-23-29-13-16-10-21(34)30-20-11-17(24(25,26)27)6-7-18(20)22(16)32-23/h6-7,9,11-13H,4-5,8,10H2,1-3H3,(H,30,34)(H,29,31,32)
InChi Key CODBZFJPKJDNDT-UHFFFAOYSA-N
Canonical SMILES CC1=C(C=C(C=N1)CCCN(C)C)NC2=NC=C3CC(=S)NC4=C(C3=N2)C=CC(=C4)C(F)(F)F
Isomeric SMILES CC1=C(C=C(C=N1)CCCN(C)C)NC2=NC=C3CC(=S)NC4=C(C3=N2)C=CC(=C4)C(F)(F)F
PubChem CID 46235922
Molecular Weight 486.56

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

18 results found

Lot NumberCertificate TypeDateItem
K2322393Certificate of AnalysisAug 21, 2023 M126487
K2322392Certificate of AnalysisAug 21, 2023 M126487
K2322391Certificate of AnalysisAug 21, 2023 M126487
K2322390Certificate of AnalysisAug 21, 2023 M126487
F2307498Certificate of AnalysisMay 08, 2023 M126487
F2308093Certificate of AnalysisMay 08, 2023 M126487
F2308092Certificate of AnalysisMay 08, 2023 M126487
F2308089Certificate of AnalysisMay 08, 2023 M126487
F2308088Certificate of AnalysisMay 08, 2023 M126487
F2307488Certificate of AnalysisMay 08, 2023 M126487
F2307497Certificate of AnalysisMay 08, 2023 M126487
F2307496Certificate of AnalysisMay 08, 2023 M126487
F2307495Certificate of AnalysisMay 08, 2023 M126487
F2307494Certificate of AnalysisMay 08, 2023 M126487
F2307493Certificate of AnalysisMay 08, 2023 M126487
F2307492Certificate of AnalysisMay 08, 2023 M126487
F2307491Certificate of AnalysisMay 08, 2023 M126487
F2307490Certificate of AnalysisMay 08, 2023 M126487

more

Related Documents

References

1. Duffey MO, Vos TJ, Adams R, Alley J, Anthony J, Barrett C, Bharathan I, Bowman D, Bump NJ, Chau R et al..  (2012)  Discovery of a potent and orally bioavailable benzolactam-derived inhibitor of Polo-like kinase 1 (MLN0905)..  J Med Chem,  55  (1): (197-208).  [PMID:22070629]

Solution Calculators